Themis Medicare’s VIRALEX effective against viral respiratory infections
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
This cost-effective tool will be of immense benefit to other high burden countries as well.
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously
The approval is for Cytomegalovirus, a type of Herpes virus
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
Subscribe To Our Newsletter & Stay Updated